Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion type Assertion NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_head.
- NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_provenance.
- NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion evidence source_evidence_literature NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_provenance.
- NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion SIO_000772 14607763 NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_provenance.
- NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion wasDerivedFrom befree-2016 NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_provenance.
- NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion wasGeneratedBy ECO_0000203 NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_provenance.